University of Colorado Cancer Center


 

Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Untreated Patients, Improvemens & Expansions, Predicting Non-responders

66 views
May 27, 2021
0 Comments
Login to view comments. Click here to Login
Oncology Grand Rounds